Catherine Novack

Stock Analyst at Jones Trading

(0.39)
# 4,082
Out of 4,888 analysts
20
Total ratings
17.65%
Success rate
-21.23%
Average return

Stocks Rated by Catherine Novack

Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $8.39
Upside: +257.57%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40$29
Current: $10.17
Upside: +185.15%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10$6
Current: $0.92
Upside: +552.17%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.51
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $24.82
Upside: +81.34%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.20
Upside: +400.00%
Korro Bio
Nov 18, 2024
Initiates: Buy
Price Target: $130
Current: $13.60
Upside: +855.88%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.31
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12$16
Current: $6.95
Upside: +130.38%
Larimar Therapeutics
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.32
Upside: +321.69%
Maintains: Buy
Price Target: $5$13
Current: $2.40
Upside: +441.67%
Initiates: Buy
Price Target: $10
Current: $4.97
Upside: +101.21%
Initiates: Buy
Price Target: $22
Current: $1.60
Upside: +1,275.00%
Downgrades: Hold
Price Target: n/a
Current: $4.55
Upside: -
Initiates: Buy
Price Target: $160
Current: $2.41
Upside: +6,527.45%